» Articles » PMID: 37061575

A Proof-of-concept Assay for Quantitative and Optical Assessment of Drug-induced Toxicity in Renal Organoids

Overview
Journal Sci Rep
Specialty Science
Date 2023 Apr 15
PMID 37061575
Authors
Affiliations
Soon will be listed here.
Abstract

Kidneys are complex organs, and reproducing their function and physiology in a laboratory setting remains difficult. During drug development, potential compounds may exhibit unexpected nephrotoxic effects, which imposes a significant financial burden on pharmaceutical companies. As a result, there is an ongoing need for more accurate model systems. The use of renal organoids to simulate responses to nephrotoxic insults has the potential to bridge the gap between preclinical drug efficacy studies in cell cultures and animal models, and the stages of clinical trials in humans. Here we established an accessible fluorescent whole-mount approach for nuclear and membrane staining to first provide an overview of the organoid histology. Furthermore, we investigated the potential of renal organoids to model responses to drug toxicity. For this purpose, organoids were treated with the chemotherapeutic agent doxorubicin for 48 h. When cell viability was assessed biochemically, the organoids demonstrated a significant, dose-dependent decline in response to the treatment. Confocal microscopy revealed visible tubular disintegration and a loss of cellular boundaries at high drug concentrations. This observation was further reinforced by a dose-dependent decrease of the nuclear area in the analyzed images. In contrast to other approaches, in this study, we provide a straightforward experimental framework for drug toxicity assessment in renal organoids that may be used in early research stages to assist screen for potential adverse effects of compounds.

Citing Articles

Landscape of human organoids: Ideal model in clinics and research.

Han X, Cai C, Deng W, Shi Y, Li L, Wang C Innovation (Camb). 2024; 5(3):100620.

PMID: 38706954 PMC: 11066475. DOI: 10.1016/j.xinn.2024.100620.


Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy.

Chehelgerdi M, Dehkordi F, Chehelgerdi M, Kabiri H, Salehian-Dehkordi H, Abdolvand M Mol Cancer. 2023; 22(1):189.

PMID: 38017433 PMC: 10683363. DOI: 10.1186/s12943-023-01873-0.

References
1.
Rehman M, Tahir M, Quaiyoom Khan A, Khan R, Oday-O-Hamiza , Lateef A . D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats. Exp Biol Med (Maywood). 2014; 239(4):465-76. DOI: 10.1177/1535370213520112. View

2.
Makris K, Spanou L . Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev. 2017; 37(2):85-98. PMC: 5198510. View

3.
Taguchi A, Kaku Y, Ohmori T, Sharmin S, Ogawa M, Sasaki H . Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell. 2013; 14(1):53-67. DOI: 10.1016/j.stem.2013.11.010. View

4.
Riedesser J, Ebert M, Betge J . Precision medicine for metastatic colorectal cancer in clinical practice. Ther Adv Med Oncol. 2022; 14:17588359211072703. PMC: 8882813. DOI: 10.1177/17588359211072703. View

5.
Lindstrom N, McMahon J, Guo J, Tran T, Guo Q, Rutledge E . Conserved and Divergent Features of Human and Mouse Kidney Organogenesis. J Am Soc Nephrol. 2018; 29(3):785-805. PMC: 5827606. DOI: 10.1681/ASN.2017080887. View